1. Home
  2. SKK vs PHGE Comparison

SKK vs PHGE Comparison

Compare SKK & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKK
  • PHGE
  • Stock Information
  • Founded
  • SKK 2013
  • PHGE 2015
  • Country
  • SKK Singapore
  • PHGE Israel
  • Employees
  • SKK N/A
  • PHGE N/A
  • Industry
  • SKK
  • PHGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • SKK
  • PHGE Health Care
  • Exchange
  • SKK NYSE
  • PHGE Nasdaq
  • Market Cap
  • SKK 12.4M
  • PHGE 14.6M
  • IPO Year
  • SKK 2024
  • PHGE N/A
  • Fundamental
  • Price
  • SKK $0.65
  • PHGE $0.47
  • Analyst Decision
  • SKK
  • PHGE Strong Buy
  • Analyst Count
  • SKK 0
  • PHGE 1
  • Target Price
  • SKK N/A
  • PHGE $15.00
  • AVG Volume (30 Days)
  • SKK 323.5K
  • PHGE 122.3K
  • Earning Date
  • SKK 02-14-2025
  • PHGE 05-15-2025
  • Dividend Yield
  • SKK N/A
  • PHGE N/A
  • EPS Growth
  • SKK 99.13
  • PHGE N/A
  • EPS
  • SKK 0.03
  • PHGE N/A
  • Revenue
  • SKK $11,301,000.00
  • PHGE N/A
  • Revenue This Year
  • SKK N/A
  • PHGE N/A
  • Revenue Next Year
  • SKK N/A
  • PHGE N/A
  • P/E Ratio
  • SKK $22.36
  • PHGE N/A
  • Revenue Growth
  • SKK 15.80
  • PHGE N/A
  • 52 Week Low
  • SKK $0.53
  • PHGE $0.44
  • 52 Week High
  • SKK $11.45
  • PHGE $4.13
  • Technical
  • Relative Strength Index (RSI)
  • SKK N/A
  • PHGE 36.07
  • Support Level
  • SKK N/A
  • PHGE $0.47
  • Resistance Level
  • SKK N/A
  • PHGE $0.57
  • Average True Range (ATR)
  • SKK 0.00
  • PHGE 0.05
  • MACD
  • SKK 0.00
  • PHGE -0.00
  • Stochastic Oscillator
  • SKK 0.00
  • PHGE 20.41

About SKK SKK HOLDINGS LIMITED

SKK Holdings Ltd is a civil engineering service provider that specializes in subsurface utility works in Singapore. It construct and maintain various public works and infrastructure projects that serve the society and the environment. Its projects are primarily the subsurface work related to projects undertaken by the Public Utilities Board (PUB) and Singapore Telecommunications Limited. The nature of these projects is related to repairing of pumping mains, sewer maintenance and pipe cable laying.

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

Share on Social Networks: